[4] – Rollins Jared Timothy (CIK 0002091483)

Rhea-AI Filing Summary

Rayonier Advanced Materials (RYAM) filed a Form 4 reporting an equity grant to a company officer. The CAO & VP, Corporate Controller received 27,663 restricted stock units on 10/10/2025. Each RSU represents a contingent right to receive one share of RYAM common stock. The award was reported at a price of $0.0000 and is held as direct ownership.

The filing lists the RSUs with a date exercisable of 10/10/2028 and an expiration date of 10/10/2028. Following the reported transaction, the officer beneficially owns 27,663 derivative securities, all directly. No open-market purchases or sales were reported.

Insights

Executive compensation and governance analyst

Routine RSU grant; administrative disclosure with neutral impact.

An RYAM officer received 27,663 RSUs on 10/10/2025, each convertible into one share. The filing records a grant price of $0.0000 and direct ownership of 27,663 derivative securities after the transaction, indicating no sale activity.

RSUs align compensation with equity value, but the excerpt provides no performance conditions or vesting detail beyond the listed exercisable and expiration dates of 10/10/2028. Without financial or scale context, this is a standard insider award.

Subsequent company disclosures may clarify vesting mechanics or settlement timing, but based on this report alone, the market impact is neutral.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Rollins Jared Timothy

(Last) (First) (Middle)

1301 RIVERPLACE BOULEVARD

SUITE 2300

(Street)

JACKSONVILLE FL 32207

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
RAYONIER ADVANCED MATERIALS INC. [ RYAM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CAO & VP, Corporate Controller

3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	10/10/2025		A		27,663		10/10/2028	10/10/2028	Common Stock	27,663	$0.0000	27,663	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of RYAM common stock.

	Brenda K. Davis, Attorney-in-Fact	10/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did RYAM report on this Form 4?

An officer (CAO & VP, Corporate Controller) received 27,663 restricted stock units on 10/10/2025.

How many RSUs were granted to the RYAM insider?

The filing discloses 27,663 RSUs, each representing the right to receive one RYAM common share.

What are the exercisable and expiration dates for the RSUs?

The RSUs list a date exercisable of 10/10/2028 and an expiration date of 10/10/2028.

What price is shown for the RSU grant on the Form 4?

The RSUs are reported at $0.0000, typical for restricted stock units that settle into shares.

How many derivative securities does the insider own after this transaction?

The officer beneficially owns 27,663 derivative securities directly after the reported grant.

Did the filing report any open-market buys or sells?

No. The report shows an award (A) of RSUs and no sales or purchases.